Stay updated on Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.

Latest updates to the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision metadata updated to v3.5.2; the previous v3.5.0 revision was removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page. This appears to be a site revision and does not modify the study details displayed.SummaryDifference0.1%

- Check45 days agoChange DetectedSystem revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check73 days agoChange DetectedRemoved the government funding lapse notice and NIH Clinical Center operating status banner, and added a Revision: v3.4.2 tag. The core study content and user-facing information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedA site-wide notice informs users about potential delays due to a lapse in government funding and notes that the NIH Clinical Center is open, and the revision tag has been updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check87 days agoChange DetectedAdditions: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4.SummaryDifference0.2%

Stay in the know with updates to Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.